Does Finerenone Interact with Agents Increasing Serum Potassium?
Finerenone and Agents Increasing Serum Potassium have a moderate drug interaction according to U.S. FDA drug labeling data. More frequent serum potassium monitoring is warranted with concomitant use due to increased risk of hyperkalemia. The mechanism involves additive effects on serum potassium elevation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Finerenone Class
- Nonsteroidal Mineralocorticoid-Receptor Antagonist
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Finerenone and Agents Increasing Serum Potassium occurs because additive effects on serum potassium elevation. Clinically, this means more frequent serum potassium monitoring is warranted with concomitant use due to increased risk of hyperkalemia. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Finerenone and your doctor is considering prescribing Agents Increasing Serum Potassium (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider